Provided by Tiger Trade Technology Pte. Ltd.

TherapeuticsMD

2.18
-0.0400-1.80%
Volume:46.44K
Turnover:103.94K
Market Cap:25.23M
PE:-116.28
High:2.28
Open:2.17
Low:2.17
Close:2.22
52wk High:2.95
52wk Low:0.9900
Shares:11.57M
Float Shares:9.49M
Volume Ratio:0.68
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.0187
EPS(LYR):-0.0527
ROE:-1.08%
ROA:-2.88%
PB:0.93
PE(LYR):-41.34

Loading ...

TherapeuticsMD Inc - Company Continues to Evaluate Strategic Alternatives Including Acquisition or Merger

THOMSON REUTERS
·
May 13

Press Release: TherapeuticsMD Announces First Quarter 2026 Financial Results

Dow Jones
·
May 13

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 12

TherapeuticsMD Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
May 09

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 06

TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
May 05

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
May 02

TherapeuticsMD Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
May 01

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 29

TherapeuticsMD Inc. Stock Sheds 5.5%, Underperforms Market

Dow Jones
·
Apr 28

TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Apr 23

TherapeuticsMD Inc. Stock Rises 5.8%, Outperforms Market

Dow Jones
·
Apr 21

TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Apr 15

TherapeuticsMD Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Apr 08

TherapeuticsMD Inc. Stock Rallies 10.0%, Outperforms Market

Dow Jones
·
Apr 07

TherapeuticsMD Explains Brief Delay In Annual Filing

TIPRANKS
·
Apr 01

TherapeuticsMD delays 2025 10-K after filing omits auditor report

Reuters
·
Apr 01

TherapeuticsMD Inc. Stock Rises Tuesday, Still Underperforms Market

Dow Jones
·
Apr 01

TherapeuticsMD Narrows 2025 Loss, Advances Royalty Strategy

TIPRANKS
·
Mar 31

TherapeuticsMD Q4 EPS $(0.06) Down From $0.01 YoY, Sales $893.000K Up From $667.000K YoY

Benzinga Earnings
·
Mar 31